Logo image of EVGN

EVOGENE LTD (EVGN) Stock Overview

USA - NASDAQ:EVGN - IL0011050551 - Common Stock

1.12 USD
-0.03 (-2.78%)
Last: 10/2/2025, 4:39:32 PM
1.1 USD
-0.02 (-1.79%)
After Hours: 10/2/2025, 4:39:32 PM

EVGN Key Statistics, Chart & Performance

Key Statistics
52 Week High2.87
52 Week Low0.95
Market Cap9.76M
Shares8.71M
Float8.63M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.25
PEN/A
Fwd PEN/A
Earnings (Next)11-19 2025-11-19/bmo
IPO06-11 2007-06-11
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


EVGN short term performance overview.The bars show the price performance of EVGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

EVGN long term performance overview.The bars show the price performance of EVGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EVGN is 1.12 USD. In the past month the price decreased by -6.67%. In the past year, price decreased by -62.16%.

EVOGENE LTD / EVGN Daily stock chart

EVGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 22.34 417.90B
AMGN AMGEN INC 13.64 160.11B
GILD GILEAD SCIENCES INC 14.28 137.18B
VRTX VERTEX PHARMACEUTICALS INC 24.14 104.83B
REGN REGENERON PHARMACEUTICALS 13.15 63.59B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.43B
ARGX ARGENX SE - ADR 85.39 48.45B
ONC BEONE MEDICINES LTD-ADR 6.03 41.03B
INSM INSMED INC N/A 32.30B
BNTX BIONTECH SE-ADR N/A 25.12B
BIIB BIOGEN INC 9.7 22.76B
NTRA NATERA INC N/A 21.99B

About EVGN

Company Profile

EVGN logo image Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Company Info

EVOGENE LTD

13 Gad Feinstein Street, Park Rehovot

Rehovot 7414002 IL

CEO: Ofer Haviv

Employees: 117

EVGN Company Website

EVGN Investor Relations

Phone: 97289311900

EVOGENE LTD / EVGN FAQ

What is the stock price of EVOGENE LTD today?

The current stock price of EVGN is 1.12 USD. The price decreased by -2.78% in the last trading session.


What is the ticker symbol for EVOGENE LTD stock?

The exchange symbol of EVOGENE LTD is EVGN and it is listed on the Nasdaq exchange.


On which exchange is EVGN stock listed?

EVGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EVOGENE LTD stock?

8 analysts have analysed EVGN and the average price target is 3.06 USD. This implies a price increase of 173.21% is expected in the next year compared to the current price of 1.12. Check the EVOGENE LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EVOGENE LTD worth?

EVOGENE LTD (EVGN) has a market capitalization of 9.76M USD. This makes EVGN a Nano Cap stock.


How many employees does EVOGENE LTD have?

EVOGENE LTD (EVGN) currently has 117 employees.


What are the support and resistance levels for EVOGENE LTD (EVGN) stock?

EVOGENE LTD (EVGN) has a support level at 1.12 and a resistance level at 1.14. Check the full technical report for a detailed analysis of EVGN support and resistance levels.


Is EVOGENE LTD (EVGN) expected to grow?

The Revenue of EVOGENE LTD (EVGN) is expected to decline by -45.72% in the next year. Check the estimates tab for more information on the EVGN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EVOGENE LTD (EVGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EVOGENE LTD (EVGN) stock pay dividends?

EVGN does not pay a dividend.


When does EVOGENE LTD (EVGN) report earnings?

EVOGENE LTD (EVGN) will report earnings on 2025-11-19, before the market open.


What is the Price/Earnings (PE) ratio of EVOGENE LTD (EVGN)?

EVOGENE LTD (EVGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.25).


What is the Short Interest ratio of EVOGENE LTD (EVGN) stock?

The outstanding short interest for EVOGENE LTD (EVGN) is 1.08% of its float. Check the ownership tab for more information on the EVGN short interest.


EVGN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EVGN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EVGN. Both the profitability and financial health of EVGN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVGN Financial Highlights

Over the last trailing twelve months EVGN reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 43.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -44.34%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%41.51%
Sales Q2Q%-3.28%
EPS 1Y (TTM)43.18%
Revenue 1Y (TTM)50.9%

EVGN Forecast & Estimates

8 analysts have analysed EVGN and the average price target is 3.06 USD. This implies a price increase of 173.21% is expected in the next year compared to the current price of 1.12.

For the next year, analysts expect an EPS growth of 29.98% and a revenue growth -45.72% for EVGN


Analysts
Analysts82.5
Price Target3.06 (173.21%)
EPS Next Y29.98%
Revenue Next Year-45.72%

EVGN Ownership

Ownership
Inst Owners1.66%
Ins Owners0.96%
Short Float %1.08%
Short Ratio1.44